Optimal Clinical Trials Platform for Progressive Multiple Sclerosis (OCTOPUS): protocol for an international, multi-arm, multi-stage, platform, randomized controlled, double-blind, phase 3 clinical trial
Sean Apap Mangion, Charles Wade, Cheryl Pugh, Matthew Burnell et autres
ABSTRACT Introduction Current treatments for multiple sclerosis (MS) do not address the pathological processes of neurodegeneration and chronic demyelination. This, coupled with the significant challenges of translating promising phase 2 results to phase 3 trial success, highlights the need for more efficient …
gb, us, au, nl (code pays fourni par la source)
0 citations
medRxiv